Changes of Muscle Insulin-like Growth Factor-I and Concentrations of Inflammatory Cytokines in Rat Skeletal Muscle Following Denervation and Diabetes-induced Atrophy

다국어 초록 (Multilingual Abstract)

[PURPOSE] Muscle atrophy is the result of several diseases and conditions. In systemic disease, many factors contribute to muscle atrophy. Insulin-like growth factor-I (IGF-I) is a local and systemic hormone that contributes to muscle growth. The aim of this study was to investigate the changes in muscle protein synthesis biomarkers and pro-inflammatory factors associated with muscle atrophy in systemic disease. [METHODS] Local muscle tissue damage was observed and compared in both streptozotocin (STZ) -induced diabetic and denervated rats. In these animal models, we measured the expression of muscle-specific IGF-1 (mIGF-1) in by real-time PCR and serum concentrations of inflammatory cytokines by ELISA. In addition, muscle mass and blood glucose levels were observed for six weeks. [RESULTS] The results showed that muscle mass was significantly lower in both experimental groups compared to the control group from week two. Over the six week period, muscle mass gradually increased in the control group, dramatically decreased in the denervated group, but interestingly, showed no significant changes in the diabetes group. Inflammatory factors including tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were significantly higher in diabetic rats than in the control group. The level of TNF-α was increased at week four; however, IL-6 levels did not change in denervated rats. The expression of mIGF-1 mRNA did not change significantly in the two experimental groups. [CONCLUSIONS] In conclusion, mIGF-1 for the proliferation of muscle cells did not have an effect on muscle atrophy among the groups. However the increase in systemic inflammatory factors may be involved in the process of muscle atrophy in diabetic rats.

참고문헌 (Reference)

1 Adams G. R., "Time course of changes in markers of myogenesis in overloaded rat skeletal muscles" 87 : 1705-1712, 1999

2 Holly J. M. P., "The role of growth hormone in diabetes mellitus" 118 : 353-364, 1988

3 Midrio M., "The denervated muscle: facts and hypotheses. A historical review" 98 : 1-21, 2006

4 Philippou A., "The Role of the Insulin-like Growth Factor 1 (IGF-1) in Skeletal Muscle Physiology" 21 : 45-54, 2007

5 Evans, W. J., "Skeletal muscle loss: cachexia, sarcopenia, and inactivity" 91 : 1123S-1127S, 2010

6 Glass D. J., "Skeletal muscle hypertrophy and atrophy signaling pathways" 37 : 1974-1984, 2005

7 Bongers K. S., "Skeletal muscle denervation causes skeletal muscle atrophy through a pathway that involves both Gadd45a and HDAC4" 305 : E907-E915, 2013

8 Egerman M. A., "Signaling pathways controlling skeletal muscle mass" 0 : 1-10, 2013

9 Sandri M., "Signaling in Muscle Atrophy and Hypertrophy" 23 : 160-170, 2008

10 Narici M. V., "Sarcopenia: characteristics, mechanisms and functional significance" 95 : 139-159, 2010

11 Velloso C. P., "Regulation of muscle mass by growth hormone and IGF-I" 154 : 557-568, 2008

12 Fan J., "Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF-binding proteins by interleukin-1" 270 : R621-R629, 1996

13 Whitman S. A., "Nrf2 modulates contractile and metabolic properties of skeletal muscle in streptozotocin-induced diabetic atrophy" 319 : 2673-2683, 2013

14 Hepple R. T., "Muscle atrophy is not always sarcopenia" 113 : 677-679, 2012

15 Pedersen B. K., "Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6" 88 : 1379-1406, 2008

16 Singleton J. R., "Microvascular Complications of Impaired Glucose Tolerance" 52 : 2867-2873, 2003

17 Rommel C., "Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways" 3 : 1009-1013, 2001

18 Musaro A., "Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle" 27 : 195-200, 2001

19 Adams G. R., "Invited Review: Autocrine/paracrine IGF-I and skeletal muscle adaptation" 93 : 1159-1167, 2002

20 Shavlakadze T., "Insulin-like growth factor I slows the rate of denervation induced skeletal muscle atrophy" 15 : 139-146, 2005

21 Krause M. P., "Impaired Macrophage and Satellite Cell Infiltration Occurs in a Muscle-Specific Fashion Following Injury in Diabetic Skeletal Muscle" 8 : e70971-, 2013

22 Haddad F., "IL-6-induced skeletal muscle atrophy" 98 : 911-917, 2005

23 Sacheck J. M., "IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1" 287 : E591-E601, 2004

24 Jørgensen J. O. L., "GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus" 291 : E899-E905, 2006

25 Eliakim A., "Fitness, Training, and the Growth Hormone→Insulin-Like Growth Factor I Axis in Prepubertal Girls" 86 : 2797-2802, 2001

26 Gosteli-Peter M. A., "Expression and regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone" 135 : 2558-2567, 1994

27 Masiello P., "Experimental NIDDM: Development of a New Model in Adult Rats Administered Streptozotocin and Nicotinamide" 47 : 224-229, 1998

28 Yach D., "Epidemiologic and economic consequences of the global epidemics of obesity and diabetes" 12 : 62-66, 2006

29 Punkt K., "Effects on skeletal muscle fibres of diabetes and Ginkgo biloba extract treatment" 101 : 53-69, 1999

30 Scheett T. P., "Effect of Exercise on Cytokines and Growth Mediators in Prepubertal Children" 46 : 429-429, 1999

31 American Diabetes Association, "Diagnosis and Classification of Diabetes Mellitus" 29 : s43-s48, 2006

32 Robertson R. P., "Diabetes: Strategies to prevent the type 2 diabetes mellitus epidemic" 6 : 128-129, 2010

33 Muller F. L., "Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production" 293 : R1159-R1168, 2007

34 Jaweed M. M., "Denervation and reinnervation of fast and slow muscles. A histochemical study in rats" 23 : 808-827, 1975

35 Midrio M., "Cordotomy-denervation interactions on contractile and myofibrillar properties of fast and slow muscles in the rat" 100 : 216-236, 1988

36 Barbieri M., "Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons" 284 : E481-E487, 2003

37 Brownlee M., "Biochemistry and molecular cell biology of diabetic complications" 414 : 813-820, 2001

38 Reid M. B., "Beyond atrophy: redox mechanisms of muscle dysfunction in chronic inflammatory disease" 589 : 2171-2179, 2011

39 Hu G., "Association of Serum C-Reactive Protein Level with Sex-Specific Type 2 Diabetes Risk: A Prospective Finnish Study" 94 : 2099-2105, 2009

40 Pellegrino C., "An electron microscope study of denervation atrophy in red and white skeletal muscle fibers" 17 : 327-349, 1963

41 Wohaieb S. A., "Alterations in free radical tissue-defense mechanisma in streptozotocin-induced diabetic rats" 36 : 1014-1018, 1987

42 DeVol D. L., "Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth" 259 : E89-E95, 1990